These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34903173)

  • 1. Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients.
    Heiderich S; Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Reitz M; Rüffert H
    BMC Anesthesiol; 2021 Dec; 21(1):315. PubMed ID: 34903173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Malignant Hyperthermia Association of the United States-Recommended Methods of Preparation for Malignant Hyperthermia-Susceptible Patients Using Dräger Zeus Anesthesia Workstations and Associated Costs.
    Neira VM; Al Madhoun W; Ghaffari K; Barrowman N; Berrigan P; Splinter W
    Anesth Analg; 2019 Jul; 129(1):74-83. PubMed ID: 29847377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebounds of sevoflurane concentration during simulated trigger-free pediatric and adult anesthesia.
    Zumsande S; Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Rüffert H; Heiderich S
    BMC Anesthesiol; 2023 Jun; 23(1):196. PubMed ID: 37291484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of anaesthesia workstation for trigger-free anaesthesia: An observational laboratory study.
    Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Rüffert H; Heiderich S
    Eur J Anaesthesiol; 2019 Nov; 36(11):851-856. PubMed ID: 31580288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
    Gunter JB; Ball J; Than-Win S
    Anesth Analg; 2008 Dec; 107(6):1936-45. PubMed ID: 19020141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.
    Shanahan H; O'Donoghue R; O'Kelly P; Synnott A; O'Rourke J
    Eur J Anaesthesiol; 2012 May; 29(5):229-34. PubMed ID: 22388705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual volatile anesthetics after workstation preparation and activated charcoal filtration.
    Müller-Wirtz LM; Godsch C; Sessler DI; Volk T; Kreuer S; Hüppe T
    Acta Anaesthesiol Scand; 2020 Jul; 64(6):759-765. PubMed ID: 32153012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.
    Birgenheier N; Stoker R; Westenskow D; Orr J
    Anesth Analg; 2011 Jun; 112(6):1363-70. PubMed ID: 21543783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Datex-Ohmeda Aestiva and Aisys anaesthetic machines for use in malignant hyperthermia susceptible patients.
    Jones C; Bennett K; Kim TW; Bulger TF; Pollock N
    Anaesth Intensive Care; 2012 May; 40(3):490-7. PubMed ID: 22577915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Washout times of desflurane, sevoflurane and isoflurane from the GE Healthcare Aisys® and Avance®, Carestation®, and Aestiva® anesthesia system.
    Kim TW; Wingate JR; Fernandez AM; Whitaker E; Tham RQ
    Paediatr Anaesth; 2013 Dec; 23(12):1124-30. PubMed ID: 23947944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.
    Prinzhausen H; Crawford MW; O'Rourke J; Petroz GC
    Can J Anaesth; 2006 Sep; 53(9):885-90. PubMed ID: 16960266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Washout of sevoflurane from the GE Avance and Amingo Carestation anesthetic machines.
    Brünner HW; Pohl S; Grond S
    Acta Anaesthesiol Scand; 2011 Oct; 55(9):1118-23. PubMed ID: 22092210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sevoflurane washout profile of seven recent anesthesia workstations for malignant hyperthermia-susceptible adults and infants: a bench test study.
    Cottron N; Larcher C; Sommet A; Fesseau R; Alacoque X; Minville V; Fourcade O; Kern D
    Anesth Analg; 2014 Jul; 119(1):67-75. PubMed ID: 24806140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia].
    Jantzen JP; Eck J; Kleemann PP
    Anaesthesist; 1989 Nov; 38(11):639-41. PubMed ID: 2635839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fresh gas flow, tidal volume, and charcoal filters on the washout of sevoflurane from the Datex Ohmeda (GE) Aisys, Aestiva/5, and Excel 210 SE Anesthesia Workstations.
    Sabouri AS; Lerman J; Heard C
    Can J Anaesth; 2014 Oct; 61(10):935-42. PubMed ID: 25069780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing a new generation anaesthetic machine for patients susceptible to malignant hyperthermia.
    Schönell LH; Sims C; Bulsara M
    Anaesth Intensive Care; 2003 Feb; 31(1):58-62. PubMed ID: 12635397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of the Dräger Fabius GS workstation for malignant hyperthermia-susceptible patients.
    Whitty RJ; Wong GK; Petroz GC; Pehora C; Crawford MW
    Can J Anaesth; 2009 Jul; 56(7):497-501. PubMed ID: 19399571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating the washout of inhalational anesthetics from the Dräger Primus anesthetic workstation: effect of exchangeable internal components.
    Crawford MW; Prinzhausen H; Petroz GC
    Anesthesiology; 2007 Feb; 106(2):289-94. PubMed ID: 17264723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anesthetic drugs and onset of malignant hyperthermia.
    Visoiu M; Young MC; Wieland K; Brandom BW
    Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.
    Kim TW; Nemergut ME
    Anesthesiology; 2011 Jan; 114(1):205-12. PubMed ID: 21169802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.